Dare Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
Dare Bioscience, Inc. filed this Current Report on Form 8-K on November 13, 2018. The filing serves to announce a business update and financial results for the three and nine months ended September 30, 2018. The company is incorporated in Delaware and is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing references a business update and financial results for the periods ended September 30, 2018, but does not explicitly detail material changes versus prior periods within the body of this 8-K document.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in this filing text. The document states that the information is furnished and not filed for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 13, 2018) for specific financial figures and operational updates.
- Verify the company's status as an emerging growth company and any related accounting standard elections.
- Confirm that the financial results for the three and nine months ended September 30, 2018, align with the company's previous guidance.
- Check for any subsequent filings that may incorporate the information from this press release by specific reference.